Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 201–300 of 1,000
Cameron, D. J., Yang, Z., Gibbs, D., Chen, H., Kaminoh, Y., Jorgensen, A., Zeng, J., Luo, L., Brinton, E., Brinton, G., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4157 · Cited by 114
Complement and immune defense: From innate immunity to human diseases
Zipfel, P. F. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.07.005 · Cited by 133
Zhou, J., Cai, B., Jang, Y. P., Pachydaki, S., Schmidt, A. M., & Sparrow, J. R. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.009 · Cited by 113
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
“Matching the distribution of DHA, CEP adducts immunolocalize in photoreceptor outer segments, the RPE, and drusen in higher abundance than age-matched controls patients[75].”
BackgroundResultInflammation and Age-Related Macular Degeneration (AMD)
Telander, D. G. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.570849 · Cited by 110
Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life
Lewandowski, D., Sander, C. L., Tworak, A., Gao, F., Xu, Q., & Skowronska‐Krawczyk, D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101037 · Cited by 120
Mao, H., Seo, S. J., Biswal, M. R., Li, H., Conners, M., Nandyala, A., Jones, K., Le, Y.-Z., & Lewin, A. S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14633 · Cited by 108
A Random Forest classifier-based approach in the detection of abnormalities in the retina
Chowdhury, A. R., Chatterjee, T., & Banerjee, S. (2018) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-018-1878-0 · Cited by 116
Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy
Li, C.-M., Presley, J. B., Zhang, X., Dashti, N., Chung, B. H., Medeiros, N. E., Guidry, C., & Curcio, C. A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400428-jlr200 · Cited by 109
“ApoB was detected in drusen by immunofluorescence (8) but not by proteomics (56), likely because the chloroform-methanol extraction used in that investigation removed core lipids and precipitated the amphipathic apoB peptide (57).”
BackgroundThe Role of Vitamin A in Retinal Diseases
Sajovic, J., Meglič, A., Glavač, D., Markelj, Š., Hawlina, M., & Fakin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031014 · Cited by 109
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 104
“drusen [14].”
McLeod, D. S., Bhutto, I., Edwards, M. M., Silver, R. E., Seddon, J. M., & Lutty, G. A. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-20049 · Cited by 106
Crabb, J. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017194 · Cited by 100
“Cite this article as Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a017194 w w w .p er sp ec ti ve si n m ed ic in e. o rg 2003; Ng et al. 2008) and with extracellular debris in drusen (Crabb et al. 2002a).”
BackgroundMethodInfluentialSelf-citationLipids, Lipoproteins, and Age-Related Macular Degeneration
Ebrahimi, K. B., & Handa, J. T. (2011) · Journal of Lipids · doi:10.1155/2011/802059 · Cited by 105
“, apoE, apoB) [67, 68].”
Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
Lengyel, I., Tufail, A., Hosaini, H. A., Luthert, P., Bird, A. C., & Jeffery, G. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1083 · Cited by 103
“The diversity of these constituents was confirmed by a recent proteome analysis.(25) Freidman et al.”
Landowski, M., Kelly, U., Klingeborn, M., Groelle, M., Ding, J.-D., Grigsby, D., & Bowes Rickman, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814014116 · Cited by 103
NLRP3 Inflammasome: Activation and Regulation in Age‐Related Macular Degeneration
Gao, J., Liu, R. T., Cao, S., Cui, J. Z., Wang, A., To, E., & Matsubara, J. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/690243 · Cited by 101
“overlap with complement activation sites [47, 51].”
Clark, A. F., & Yorio, T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1106 · Cited by 116
Léveillard, T., Philp, N. J., & Sennlaub, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030762 · Cited by 113
“However, large, soft drusen (>125 mm in diameter) contain lipids, cellular debris, and at least 129 distinct proteins and are enriched in carboxyethylpyrrole protein adducts, biomarkers of oxidative stress which are associated with AMD [32,33].”
BackgroundMacular dystrophies mimicking age-related macular degeneration
Saksens, N. T. M., Fleckenstein, M., Schmitz-Valckenberg, S., Holz, F. G., den Hollander, A. I., KEUNEN, J. E. E., Boon, C. J. F., & Hoyng, C. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.11.001 · Cited by 112
“Drusen are known to contain carbohydrates, zinc, and at least 129 different proteins, including apolipoproteins and excluding extracellular matrix (Anderson et al., 2001; Crabb et al., 2002; Lengyel et al., 2007; Li et al., 2005; Malek et al., 2003; Mullins and Hageman, 1999; Mullins et al., 2000).”
BackgroundVogt, S. D., Curcio, C. A., Wang, L., Li, C.-M., McGwin, G., Medeiros, N. E., Philp, N. J., Kimble, J. A., & Read, R. W. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.002 · Cited by 104
“Drusen contain complement components C1q, C3, C5, and C5b-9 (Anderson et al., 2002; Crabb et al., 2002; Hageman et al., 2001; Mullins et al., 2000; Wang et al., 2010b).”
BackgroundMicklisch, S., Lin, Y., Jacob, S., Karlstetter, M., Dannhausen, K., Dasari, P., von der Heide, M., Dahse, H.-M., Schmölz, L., Grassmann, F., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0776-3 · Cited by 101
“This surface attachment is in agreement with the reported ARMS2 binding to extracellular matrix proteins [2, 26] and the localization of ARMS2 close to the drusen, which represent accumulated cellular debris as shown by proteome analysis and immune staining [26, 27].”
BackgroundResultControl of Chemokine Gradients by the Retinal Pigment Epithelium
Shi, G., Maminishkis, A., Banzon, T., Jalickee, S., Li, R., Hammer, J., & Miller, S. S. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1816 · Cited by 102
Zipfel, P. F., Lauer, N., & Skerka, C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_2 · Cited by 115
“Multiple complement components, regulators, complement activation products and inflammatory proteins are identified in drusen, including C3, C3d, the terminal components C5, C6, C7, C8 and C9, terminal complement regulators vitronectin and clusterin, apolipoproteins apoA1, apoA4 and apoE as well as thrombospondin, ser…”
BackgroundNrf2 Is an Attractive Therapeutic Target for Retinal Diseases
Nakagami, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7469326 · Cited by 106
“Drusen deposits, which are initially formed by oxidized lipids, have been shown to be associated with AMD, along with laminar deposits in Bruch’s membrane [5, 6].”
BackgroundDietary glycemic index and the risk of age-related macular degeneration
Kaushik, S., Wang, J. J., Flood, V. M., Tan, J. S. L., Barclay, A. W., Wong, T. Y., Brand-Miller, J. C., & Mitchell, P. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1104 · Cited by 112
“For AMD, it seems likely that oxidative stress results in protein modifications that contribute to the development of drusen (37, 38).”
BackgroundOn the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101
Chiu, C.-J., Liu, S., Willett, W. C., Wolever, T. M., Brand-Miller, J. C., Barclay, A. W., & Taylor, A. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00382.x · Cited by 100
Natoli, R., Fernando, N., Jiao, H., Racic, T., Madigan, M., Barnett, N. L., Chu-Tan, J. A., Valter, K., Provis, J., & Rutar, M. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21672 · Cited by 97
Lin, M. K., Yang, J., Hsu, C. W., Gore, A. M., Bassuk, A. G., Brown, L. M., Colligan, R. M., Sengillo, J. D., Mahajan, V. B., & Tsang, S. H. (2018) · Aging Cell · doi:10.1111/acel.12710 · Cited by 107
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
Nashine, S. (2021) · Cells · doi:10.3390/cells10092483 · Cited by 111
Recent Advances in Age-Related Macular Degeneration Therapies
Fabre, M., Mateo, L., Lamaa, D., Baillif, S., Pagès, G., Demange, L., Ronco, C., & Benhida, R. (2022) · Molecules · doi:10.3390/molecules27165089 · Cited by 111
Genetic factors of age-related macular degeneration
Tuo, J., Bojanowski, C. M., & Chan, C. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.001 · Cited by 110
“(Ambati et al., 2003b; Crabb et al., 2002; Mullins et al., 2000).”
Johansson, I., Monsen, V. T., Pettersen, K., Mildenberger, J., Misund, K., Kaarniranta, K., Schønberg, S., & Bjørkøy, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1061170 · Cited by 104
Hollyfield, J. G., Perez, V. L., & Salomon, R. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8110-z · Cited by 97
Self-citationElongation of Axons during Regeneration Involves Retinal Crystallin β b2 (crybb2)
Liedtke, T., Schwamborn, J. C., Schröer, U., & Thanos, S. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600245-mcp200 · Cited by 100
“Crybb2 protein has been detected within the retina, brain, and testis (44, 50), and crybb2 mRNA has been reported in various tissues including the retina (50).”
BackgroundInflammatory Mechanisms of Age-related Macular Degeneration
Knickelbein, J. E., Chan, C.-C., Sen, H. N., Ferris, F. L., & Nussenblatt, R. B. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000073 · Cited by 97
An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology
Berber, P., Grassmann, F., Kiel, C., & Weber, B. H. F. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0234-z · Cited by 93
Chen, M., Muckersie, E., Robertson, M., Forrester, J. V., & Xu, H. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.005 · Cited by 99
The proteome of central and peripheral retina with progression of age-related macular degeneration
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1395 · Cited by 99
“For example, the identification of complement factor H polymorphisms associated with AMD built on several lines of evidence obtained from distinct approaches including immunohistochemistry,(44) human genetics, and proteomic analysis of drusen.(27) In a parallel example from our own study, we found downregulation of GU…”
BackgroundMethodKenney, M. C., Chwa, M., Atilano, S. R., Pavlis, J. M., Falatoonzadeh, P., Ramirez, C., Malik, D., Hsu, T., Woo, G., Soe, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054339 · Cited by 96
“In AMD eyes, drusen have an accumulation of complementassociated proteins including C3 [52,53].”
BackgroundErie, J. C., Good, J. A., Butz, J. A., & Pulido, J. S. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.08.014 · Cited by 102
Zhu, D., Wu, J., Spee, C., Ryan, S. J., & Hinton, D. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809393200 · Cited by 95
Hollyfield, J. G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4478 · Cited by 108
“In addition, it was found that these CEP adducts were more prevalent in AMD donor eyes than in RPE/Bruch’s membrane/ choroid tissues from normal age-matched donor tissue.(9) Plasma samples from patients with AMD contained 40% higher levels of CEP-adducted protein and autoantibodies to CEP than were present in plasma o…”
BackgroundSelf-citationHistopathology of age-related macular degeneration
Kang, S. J., & Grossniklaus, H. E. (2012) · CRC Press eBooks · doi:10.1201/b14548-2 · Cited by 99
Mo, F. M., Proia, A. D., Johnson, W. H., Cyr, D., & Lashkari, K. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3910 · Cited by 105
“Some drusen constituents identified in proteomic studies include proinflammatory stimuli.(4,7,8) It is currently accepted that inflammation plays an important role in the pathogenic progression of AMD.”
Proteomic analysis of vitreous from diabetic macular edema
Ouchi, M., West, K. A., Crabb, J. W., Kinoshita, S., & Kamei, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.020 · Cited by 98
Self-citationMolecular genetics of AMD and current animal models
Edwards, A. O., & Malek, G. (2007) · Angiogenesis · doi:10.1007/s10456-007-9064-2 · Cited by 107
Functions of crystallins in and out of lens: Roles in elongated and post-mitotic cells
Slingsby, C., & Wistow, G. J. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.02.006 · Cited by 100
“…βA1/3, βA4, βB2 and γS-crystallins were identified by mass spectroscopy in drusen, deposits basal to the RPE that may be associated with age-related macular degeneration (AMD), in humans, while βB2 and γS-crystallins were similarly detected in monkey drusen (Crabb et al., 2002; Umeda et al., 2005).”
BackgroundGeorge, S. M., Lu, F., Rao, M., Leach, L. L., & Gross, J. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100969 · Cited by 104
Age-Related Macular Degeneration, a Mathematically Tractable Disease
Curcio, C. A., Kar, D., Owsley, C. J., Sloan, K. R., & Ach, T. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.3.4 · Cited by 101
“11,60 high-risk area 131 or combined drusen across the retina 132 so that high-risk drusen represented a very small proportion of the total.”
Autoimmunity in retinal degeneration: Autoimmune retinopathy and age-related macular degeneration
Morohoshi, K., Goodwin, A. M., Ohbayashi, M., & Ono, S. J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.003 · Cited by 108
Interactions between Important Regulatory Proteins and Human αB Crystallin
Ghosh, J. G., Shenoy, A. K., & Clark, J. I. (2007) · Biochemistry · doi:10.1021/bi700149h · Cited by 101
Relationship between Oxidative Stress, Circadian Rhythms, and AMD
Fanjul‐Moles, M. L., & López-Riquelme, G. O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7420637 · Cited by 107
“Drusen are lipid-rich, sub-RPE deposits that contain a variety of proteins, including vitronectin, components of the terminal complement cascade, and bamyloid [135, 136].”
BackgroundMammadzada, P., Corredoira, P. M. F., & André, H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03422-9 · Cited by 99
Apolipoprotein Localization in Isolated Drusen and Retinal Apolipoprotein Gene Expression
Li, C.-M., Clark, M. E., Chimento, M. F., & Curcio, C. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1446 · Cited by 93
Drusen and pachydrusen: the definition, pathogenesis, and clinical significance
Zhang, X., & Sivaprasad, S. (2020) · Eye · doi:10.1038/s41433-020-01265-4 · Cited by 102
Proteomics in 2002: A Year of Technical Development and Wide-Ranging Applications
Figeys, D. (2003) · Analytical Chemistry · doi:10.1021/ac030142m · Cited by 95
Estimation of Systemic Complement C3 Activity in Age-Related Macular Degeneration
Sivaprasad, S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.515 · Cited by 94
“Drusen, the hallmark of AMD, constitute many components of the complement cascade including C3 complement fragments.(7,21) Components of chronically sequestrated debris in AMD may be potential activators of the proteolytic cascade, including apoptotic cells, nuclear fragments, and membrane-bound vesicles.”
BackgroundInvolvement of Nrf2 in Ocular Diseases
Batliwala, S. Y., Xavier, C., Liu, Y., Wu, H., & Pang, I.-H. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1703810 · Cited by 95
“The authors identified many forms of protein oxidative modifications, including cross-linked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts in drusen [37, 38].”
BackgroundGenetics of age-related macular degeneration: current concepts, future directions
DeAngelis, M. M., Silveira, A. C., Carr, E. A., & Kim, I. K. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.577129 · Cited by 94
Hu, P., Herrmann, R., Bednar, A., Saloupis, P., Dwyer, M. A., Yang, P., Qi, X., Thomas, R. S., Jaffe, G. J., Boulton, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307574110 · Cited by 89
Maeda, A., Crabb, J. W., & Palczewski, K. (2004) · Biochemistry · doi:10.1021/bi048016f · Cited by 101
Self-citationLooking Chloride Channels Straight in the Eye: Bestrophins, Lipofuscinosis, and Retinal Degeneration
Hartzell, C., Qu, Z., Putzier, I., Artinian, L., Chien, L.-T., & Cui, Y. (2005) · Physiology · doi:10.1152/physiol.00021.2005 · Cited by 89
“Drusen contains proteins characteristic of immune processes, suggesting that it is produced as a consequence of inflammation (3, 13, 29, 30).”
BackgroundYang, Y., & Cvekl, A. (2016) · Einstein Journal of Biology and Medicine · doi:10.23861/ejbm20072347 · Cited by 98
“The increased presence of αB- and other crystallins in the drusen of patients with age-related macular degeneration (AMD) raises the possibility that the pathology of AMD is linked to the abnormal expression of crystallins (Crabb et al., 2002).”
BackgroundMettu, P. S., Wielgus, A. R., Ong, S. S. Y., & Cousins, S. W. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.006 · Cited by 102
Opportunities for organoids as new models of aging
Hu, J. L., Todhunter, M. E., LaBarge, M. A., & Gartner, Z. J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709054 · Cited by 87
“Although their causal role in pathogenesis is disputed, protein and lipid-protein aggregates are prominently associated with central nervous system dysfunction, such as the infamous tangles, amyloids, and Lewy bodies in neurodegenerative disease, and the retinal drusen in age-related macular degeneration (Crabb et al.…”
The eye: A window to the soul of the immune system
Perez, V. L., Saeed, A. M., Tan, Y. C. R. S., Urbieta, M., & Cruz‐Guilloty, F. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.011 · Cited by 93
“analyzed drusen from AMD patient donor eyes with mass spectrometry and identified over a hundred different proteins [48].”
BackgroundRetinal degeneration from oxidative damage
Cingolani, C., Rogers, B. S., Lu, L., Kachi, S., Shen, J., & Campochiaro, P. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.032 · Cited by 93
Age-Related Macular Degeneration and Retinal Protein Modification by 4-Hydroxy-2-nonenal
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1058 · Cited by 89
The spectrum of phenotypes caused by variants in the CFH gene
Boon, C. J. F., van de Kar, N. C. A. J., Klevering, B. J., KEUNEN, J. E. E., Cremers, F. P. M., Klaver, C. C. W., Hoyng, C. B., Daha, M. R., & den Hollander, A. I. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.013 · Cited by 105
Towards an understanding of age-related macular disease
Bird, A. C. (2003) · Eye · doi:10.1038/sj.eye.6700562 · Cited by 102
γN‐crystallin and the evolution of the βγ‐crystallin superfamily in vertebrates
Wistow, G., Wyatt, K., David, L., Gao, C., Bateman, O., Bernstein, S., Tomarev, S., Segovia, L., Slingsby, C., & Vihtelic, T. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04655.x · Cited by 91
Liu, J., Copland, D. A., Theodoropoulou, S., Chiu, H. A. A., Barba, M. D., Mak, K. W., Mack, M., Nicholson, L. B., & Dick, A. D. (2016) · Scientific Reports · doi:10.1038/srep20639 · Cited by 100
Lin, J. B., Tsubota, K., & Apte, R. S. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.3 · Cited by 91
Flores‐Bellver, M., Mighty, J., Aparicio‐Domingo, S., Li, K. V., Shi, C., Zhou, J., Cobb, H., McGrath, P. S., Michelis, G., Lenhart, P., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12165 · Cited by 96
“Remarkably, EVs secreted by RPE cells within an AMD-like environment significantly enhanced the release of AMD-associate proteins ApoE, Aβ, CLU, VIN andVTN, all crucial proteins in drusen formation (Crabb et al., 2002).”
BackgroundInfluentialEliminating Complement Factor D Reduces Photoreceptor Susceptibility to Light-Induced Damage
Rohrer, B., Guo, Y., Kunchithapautham, K., & Gilkeson, G. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0282 · Cited by 90
“org/cgi/content/full/48/11/5282/ DC1) with those proteins accumulated in drusen.(40) Both wet and dry ARMD are characterized by the presence of drusen, which consist of extracellular deposits of material.”
BackgroundFundus Autofluorescence and RPE Lipofuscin in Age-Related Macular Degeneration
Sparrow, J. R., & Duncker, T. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041302 · Cited by 99
“AGEs incite inflammatory processes and since they are detected in drusen [63, 64], they reflect a link between RPE bisretinoid lipofuscin and the formation of sub-RPE deposits.”
BackgroundAssessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers
Gu, J., Pauer, G. J. T., Yue, X., Narendra, U., Sturgill, G. M., Bena, J., Gu, X., Peachey, N. S., Salomon, R. G., Hagstrom, S. A., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800453-mcp200 · Cited by 90
“From such observations, oxidative protein modifications were hypothesized to serve as catalysts of AMD pathology (11, 15, 17).”
BackgroundMethodSelf-citationBaird, P. N., Robman, L. D., Richardson, A. J., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn018 · Cited by 90
The Human Eye Proteome Project: Perspectives on an emerging proteome
Semba, R. D., Enghild, J. J., Venkatraman, V., Dyrlund, T. F., & Eyk, J. E. V. (2013) · PROTEOMICS · doi:10.1002/pmic.201300075 · Cited by 94
Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration
İlhan, N., Dağlıoğlu, M. C., İlhan, Ö., Çoşkun, M., Tuzcu, E. A., Kahraman, H., & Keskın, U. (2014) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2014.921715 · Cited by 94
The Minnesota Grading System of Eye Bank Eyes for Age-Related Macular Degeneration
Olsen, T. W., & Feng, X. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0342 · Cited by 90
“There have been recent advances in our ability to study specific protein modifications that occur in pathologic conditions.(21,22) By combining sophisticated proteomic technology with a detailed system of tissue categorization (MGS), we hope to identify protein modifications unique to pathologic aging that occurs in A…”
BackgroundUltrastructure of the human retina in aging and various pathological states
Nag, T. C., & Wadhwa, S. (2012) · Micron · doi:10.1016/j.micron.2012.01.011 · Cited by 88
Charbel Issa, P., Victor Chong, N., & Scholl, H. P. N. (2011) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1568-6 · Cited by 87
Rutar, M., Provis, J. M., & Valter, K. (2010) · Current Eye Research · doi:10.3109/02713681003682925 · Cited by 86
Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate
Zhang, B., & Osborne, N. N. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.067 · Cited by 88
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Błasiak, J., Sobczuk, P., Pawłowska, E., & Kaarniranta, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101735 · Cited by 90
“who isolated microgram quantities of drusen and Bruch’s membrane for proteome analysis (Crabb et al., 2002).”
Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells
Suuronen, T., Nuutinen, T., Ryhänen, T., Kaarniranta, K., & Salminen, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.135 · Cited by 93
The Human Eye Proteome Project: Updates on an Emerging Proteome
Ahmad, M. T., Zhang, P., Dufresne, C. P., Ferrucci, L., & Semba, R. D. (2018) · PROTEOMICS · doi:10.1002/pmic.201700394 · Cited by 90
Yoon, K. D., Yamamoto, K., Ueda, K., Zhou, J., & Sparrow, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041309 · Cited by 88
“CEL and CML along with pentosidine have all been shown to increase with age in human Bruch’s membrane [14,15,17,18] and are reported to be prominent in both neovascular and atrophic AMD [16,43].”
BackgroundClark, S. J., Bishop, P. N., & Day, A. J. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381342 · Cited by 84
Zinc Nutrition and Inflammation in the Aging Retina
Gilbert, R. M., Pető, T., Lengyel, I., & Emri, E. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801049 · Cited by 88
“The composition of sub-RPE deposits, the so-called drusen, is complex [173, 174].”
BackgroundOmics Biomarkers in Ophthalmology
Lauwen, S., de Jong, E. K., Lefeber, D. J., & den Hollander, A. I. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21809 · Cited by 94
“36 These findings support a role of increased oxidative stress as an important environmental risk factor for AMD.”
BackgroundToll-like receptor polymorphisms and age-related macular degeneration
Edwards, A. O., Chen, D., Fridley, B. L., James, K. M., Wu, Y., Abecasis, G., Swaroop, A., Othman, M., Branham, K., Iyengar, S. K., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1378 · Cited by 84
Wang, J., Ohno-Matsui, K., Yoshida, T., Kojima, A., Shimada, N., Nakahama, K.-I., Safranova, O., Iwata, N., Saido, T. C., Mochizuki, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.712 · Cited by 80
“Recent proteomic analyses have shown that drusen contain many proteins, such as cholesterol, apolipoproteins B and E, C-reactive protein, clusterin, vitronectin, and amyloid (A ) (24, 29, 30).”
BackgroundStructural Characterization of Clusterin-Chaperone Client Protein Complexes
Wyatt, A. R., Yerbury, J. J., & Wilson, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033688 · Cited by 81
Kay, P., Yang, Y. C., & Paraoan, L. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12070 · Cited by 79
“The precise function of clusterin has not been defined, but its presence in Drusen suggests that it may be involved in their formation [116, 117], therefore contributing to one of the greatest hallmarks of AMD.”
Rohrer, B., Pinto, F. R., Hulse, K. E., Lohr, H. R., Zhang, L., & Almeida, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405085200 · Cited by 93
Klettner, A., Kauppinen, A., Błasiak, J., Roider, J., Salminen, A., & Kaarniranta, K. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.013 · Cited by 92
“…and advanced glycation endproducts and these are all molecular sources of oxidative stress (Blasiak and Szaflik, 2011; Cai et al., 2012; Crabb et al., 2002; De La Paz and Anderson, 1992; Glenn et al., 2009; Handa, 2012; Klettner, 2012; Schutt et al., 2003; Uchiki et al., 2012; Yoon et…”
Background
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.